SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Voodoo who wrote (5017)7/27/1998 5:20:00 AM
From: Bill Wexler  Read Replies (1) of 7041
 
The Zonagen fraud continues its price decline.

<<This is my very first witness to the issuance of a "fraudulent patent">>

The first Immumax patent was for a copy of Chitosan. it was indeed fraudulent and it was rejected. The company then failed to disclose this in SEC filings. These are facts that can't be disputed. As far as this patent is concerned, it's probably for a method of use.

<<Hi BW! Did they "buy" this one too?>>

I'm betting that they did, considering that they bought the two worthless Vasomax patents.

Zonagen is a fraud and a scam, and that's EXACTLY why the stock is being dumped in spite of all this seemingly "good" news.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext